Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 64

1.

Safety and pharmacokinetics of sodium nitrite in patients with subarachnoid hemorrhage: a phase IIa study.

Oldfield EH, Loomba JJ, Monteith SJ, Crowley RW, Medel R, Gress DR, Kassell NF, Dumont AS, Sherman C.

J Neurosurg. 2013 Sep;119(3):634-41. doi: 10.3171/2013.3.JNS13266. Epub 2013 May 24.

PMID:
23706046
2.

Nitrite infusions to prevent delayed cerebral vasospasm in a primate model of subarachnoid hemorrhage.

Pluta RM, Dejam A, Grimes G, Gladwin MT, Oldfield EH.

JAMA. 2005 Mar 23;293(12):1477-84.

PMID:
15784871
3.

Reversal of cerebral vasospasm via intravenous sodium nitrite after subarachnoid hemorrhage in primates.

Fathi AR, Pluta RM, Bakhtian KD, Qi M, Lonser RR.

J Neurosurg. 2011 Dec;115(6):1213-20. doi: 10.3171/2011.7.JNS11390. Epub 2011 Sep 2.

4.

Electroencephalographic Response to Sodium Nitrite May Predict Delayed Cerebral Ischemia After Severe Subarachnoid Hemorrhage.

Garry PS, Rowland MJ, Ezra M, Herigstad M, Hayen A, Sleigh JW, Westbrook J, Warnaby CE, Pattinson KT.

Crit Care Med. 2016 Nov;44(11):e1067-e1073.

5.
6.

Safety and feasibility of long-term intravenous sodium nitrite infusion in healthy volunteers.

Pluta RM, Oldfield EH, Bakhtian KD, Fathi AR, Smith RK, Devroom HL, Nahavandi M, Woo S, Figg WD, Lonser RR.

PLoS One. 2011 Jan 10;6(1):e14504. doi: 10.1371/journal.pone.0014504.

7.

Dose-escalation study of intravenous nicardipine in patients with aneurysmal subarachnoid hemorrhage.

Flamm ES, Adams HP Jr, Beck DW, Pinto RS, Marler JR, Walker MD, Godersky JC, Loftus CM, Biller J, Boarini DJ, et al.

J Neurosurg. 1988 Mar;68(3):393-400.

PMID:
3343611
9.

Prolonged intravenous infusion of sodium nitrite delivers nitric oxide (NO) in humans.

Pluta RM.

Acta Neurochir Suppl. 2013;115:49-51. doi: 10.1007/978-3-7091-1192-5_11.

PMID:
22890643
10.

Medical complications of aneurysmal subarachnoid hemorrhage: a report of the multicenter, cooperative aneurysm study. Participants of the Multicenter Cooperative Aneurysm Study.

Solenski NJ, Haley EC Jr, Kassell NF, Kongable G, Germanson T, Truskowski L, Torner JC.

Crit Care Med. 1995 Jun;23(6):1007-17.

PMID:
7774210
11.

Intrasylvian hematoma caused by ruptured middle cerebral artery aneurysms predicts recovery from poor-grade subarachnoid hemorrhage.

Fukuda H, Hayashi K, Moriya T, Nakashita S, Lo BW, Yamagata S.

J Neurosurg. 2015 Sep;123(3):686-92. doi: 10.3171/2014.10.JNS141658. Epub 2015 May 22.

PMID:
26052880
12.

[Effect of high dose nicardipine in patients with ruptured cerebral aneurysm].

Kitano H, Matsuda M.

Nihon Geka Hokan. 1993 Nov 1;62(6):287-93. Japanese.

PMID:
8092922
13.

Milrinone for the treatment of cerebral vasospasm after subarachnoid hemorrhage: report of seven cases.

Arakawa Y, Kikuta K, Hojo M, Goto Y, Ishii A, Yamagata S.

Neurosurgery. 2001 Apr;48(4):723-8; discussion 728-30.

PMID:
11322432
14.

Phase II trial of tirilazad in aneurysmal subarachnoid hemorrhage. A report of the Cooperative Aneurysm Study.

Haley EC Jr, Kassell NF, Alves WM, Weir BK, Hansen CA.

J Neurosurg. 1995 May;82(5):786-90.

PMID:
7714603
15.

[Clinical significance of natriuretic peptides in patients with aneurysmal subarachnoid hemorrhage].

Tsubokawa T, Kurita H, Kaneko N, Iino N, Shiokawa Y.

No To Shinkei. 2003 Nov;55(11):953-60. Japanese.

PMID:
14727535
16.

Intra-arterial infusion of papaverine combined with intravenous administration of high-dose nicardipine for cerebral vasospasm.

Yoshimura S, Tsukahara T, Hashimoto N, Kazekawa K, Kobayashi A.

Acta Neurochir (Wien). 1995;135(3-4):186-90.

PMID:
8748812
17.

[Effects of traumatic subarachnoid hemorrhage on pathological properties in diffuse brain injury: a comparison with aneurysmal subarachnoid hemorrhage].

Fukuda T, Mikoshiba M, Fukushima C, Nishi T, Nakajima S, Hasue M, Ikeda K, Sengoku Y, Ito H.

No Shinkei Geka. 1996 Aug;24(8):723-31. Japanese.

PMID:
8741407
18.

No effect of enoxaparin on outcome of aneurysmal subarachnoid hemorrhage: a randomized, double-blind, placebo-controlled clinical trial.

Siironen J, Juvela S, Varis J, Porras M, Poussa K, Ilveskero S, Hernesniemi J, Lassila R.

J Neurosurg. 2003 Dec;99(6):953-9.

PMID:
14705720
19.

A phase II clinical trial of recombinant human tissue-type plasminogen activator against cerebral vasospasm after aneurysmal subarachnoid hemorrhage.

Sasaki T, Ohta T, Kikuchi H, Takakura K, Usui M, Ohnishi H, Kondo A, Tanabe H, Nakamura J, Yamada K, et al.

Neurosurgery. 1994 Oct;35(4):597-604; discussion 604-5.

PMID:
7808602
20.

NEWTON: Nimodipine Microparticles to Enhance Recovery While Reducing Toxicity After Subarachnoid Hemorrhage.

Hänggi D, Etminan N, Macdonald RL, Steiger HJ, Mayer SA, Aldrich F, Diringer MN, Hoh BL, Mocco J, Strange P, Faleck HJ, Miller M.

Neurocrit Care. 2015 Oct;23(2):274-84. doi: 10.1007/s12028-015-0112-2.

PMID:
25678453

Supplemental Content

Support Center